Canada's Drug Agency | Homepage

Shaping Change

2024 – 2025 Annual Report

Symposium 2026 Call for Abstracts — Now Open

Read more about Symposium 2026 Call for Abstracts — Now Open

Evolving the Clinician Group Input Process in Drug Reimbursement Reviews

Read more about Evolving the Clinician Group Input Process in Drug Reimbursement Reviews

Canada’s Drug Agency Welcomes Distinguished Healthcare Leader Dr. Robert Bell as New Board Chair

Read more about Canada’s Drug Agency Welcomes Distinguished Healthcare Leader Dr. Robert Bell as New Board Chair

Featured Reports

All Reports
All Reports

Powering evidence-informed drug and health technology decisions for sustainable, world-class health care for all

We are experts at finding, interpreting, and assembling the best available information, and we know that evidence is the foundation of good decision-making.

Learn More
National Capital Region's Top Employers 2025 logo

A National Capital Region’s top employer

National Capital Region's Top Employers 2025 logo

We are proud and excited to share that our organization has been named one of the National Capital Region's top employers for 2025.

Read More

Latest News

All News

Canada’s Drug Agency Publishes New Report on Enzyme Deficiency Testing for Patients Receiving Fluoropyrimidine-Based Chemotherapy

Canada’s Drug Agency has conducted a new health technology review exploring the evolving landscape of dihydropyrimidine dehydrogenase (DPD) enzyme ...

Supporting Informed Decisions on Biomarker Testing in Cancer Care — Consultation Now Open

Current consultation status: Open  Consultation period: August 8 to September 30, 2025 The Promise of Precision Medicine Precision medicine capitalizes ...

From Overcrowding to Innovation: A System-Wide Look at Emergency Department Challenges

New reports should inform health system planning on emergency and urgent care services Access to Health Care Remains Under Strain Many people in Canada ...

Symposium 2026 Call for Abstracts — Now Open 

We are now accepting abstracts for workshops, panels, presentations, and posters for Symposium 2026, to be held from Wednesday, April 22 to Friday ...

Evolving the Clinician Group Input Process in Drug Reimbursement Reviews 

Clinician group input is vital to the work we do at Canada’s Drug Agency (CDA-AMC), including the reimbursement review and deliberation processes. The ...

Canada’s Drug Agency Welcomes Distinguished Healthcare Leader Dr. Robert Bell as New Board Chair

Canada’s Drug Agency announces today that Dr. Robert (Bob) Bell, a distinguished health care leader, has been elected as the new Chair of the Board of ...
All News

Canada’s Drug Agency

Canada’s Drug Agency is a pan-Canadian health organization, created and funded by Canada’s federal, provincial, and territorial governments.

We provide Canada’s health system leaders with independent evidence and advice so they can make informed drug, health technology, and health system decisions, and we collaborate with national and international partners to enhance our collective impact. 

Upcoming Events

All Events

CAPT 2025 Annual Conference 

-
all day
Read More CAPT 2025 Annual Conference 

CAHR Market Access Forum (MAF)

5:00 AM - 5:00 PM (EDT)
Read More CAHR Market Access Forum (MAF)

Market Access Summit

-
all day
Read More Market Access Summit
All Events
postcard

Canada’s Drug Agency recognizes the traditional territories, rights, and diversity of all First Nations, Inuit, and Métis communities across Canada. Indigenous Peoples have been, and continue to be, excluded from and harmed by Canada’s health care systems. In the spirit of reconciliation, we are committed to addressing these inequities alongside Indigenous communities.